Book Value per Share: Liquidia Corporation (LQDA)

Graphic logo of Liquidia Corporation (LQDA)

Liquidia Corporation (LQDA) management demonstrates high proficiency in patent legal defense and market entry preparation, as evidenced by the stock quotes shown on this chart. The business relies on unique drug delivery methods via specialized inhalers, creating an indispensable therapeutic cycle. Meanwhile, the current figure stands at 2.17, as the R&D stage and legal expenses temporarily constrain operational efficiency until mass sales commence.

Liquidia Corp (LQDA): Share Book Value from 07/04/2022 to 10/28/2026

liquidia.com - analytical breakdowns and key metrics (LQDA)

- price and consensus price forecast:
Stock Price Liquidia Technologies|LQDA - Broker Consensus Forecast
- market capitalization data:
Market Capitalization Liquidia Corporation|LQDA - Enterprise Value
- book capitalization data:
Net Assets per Single Share Liquidia|LQDA - Net Asset Value|Market Capitalization to Book Value Ratio liquidia.com|LQDA - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Liquidia Corporation|LQDA - Long-Term Debt to Capital|Short-Term Debt to Equity Liquidia|LQDA - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Liquidia Corporation
Fundamental company valuation:Liquidia Technologies - LQDA
Manufactured products of Liquidia

For a conservative investor, this indicator serves as a measure of the real value of net assets. Amid patent wars, Liquidia Corporation (LQDA) capital acts as a survival guarantee during protracted legal disputes. By analyzing the projected book value per share on GURU.Markets, an investor sees the remaining equity after deducting all liabilities. Growth in this metric confirms resilience to regulatory shocks, while a stable trend signals the issuer's continued solvency.

Competitors of Liquidia Corporation (LQDA)

Haleon Group (HLN) - Book Value per Share|KVUE - Equity per Share|VRNA: Book Value per Share|MENS (jyongbio.com) - Book Value per Share|Net Assets per Single Share Ligand LGND|Share Book Value Amneal Pharmaceuticals, Inc.|Perrigo Company (PRGO) - Book Value per Share|Accounting Value of a Share Alvotech Biopharmaceuticals (ALVO)|Book Value per Share GLPG (Galapagos NV)|anipharmaceuticals.com - Book Value per Share|Net Assets per Single Share MannKind (MNKD)|AMPH: Accounting Value of a Share|PCRX (Pacira) - Net Assets per Single Share|ARS Corp (SPRY) - Accounting Value per Share|TBPH (Theravance Biopharma) - Book Value per Share|Book Value per Share aquestive.com (AQST)|scPharmaceuticals Inc. (SCPH) - Accounting Value per Share|Accounting Value of a Share TECX (tectonictx.com)|TNXP: Net Assets per Single Share|SXTC - Net Asset Value per Share|Accounting Value per Share Eupraxia Pharma EPRX|BHST - Book Price of a Share|Book Value per Share eXoZymes EXOZ|Oramed Pharmaceuticals Inc. (ORMP) - Accounting Value of a Share|Book Value per Share ENTX (Entera Bio Ltd)|Net Asset Value per Share HYFT|ABVC BioPharma (ABVC) - Net Assets per Single Share|Accounting Value of a Share CPIX (cumberlandpharma.com)|Net Assets per Single Share Quantum BioPharma QNTM|Net Assets per Single Share FibroGen Inc FGEN|Book Value per Share TELO (Telomir Pharma)|RANI: Net Assets per Share|Net Assets per Single Share SNYR (synergychc.com)|Book Value of One Share Rallybio|LEXX (Lexaria Bioscience Corp) - Accounting Value per Share|Book Value per Share Pulmatrix Inc|PTHL (Pheton Holdings Ltd) - Book Value per Share|Net Assets per Share aptorumgroup.com (APM)|LYRA - Book Value per Share|Equity per Share Impact BioMedical, Inc. IBO|Book Value per Share TNFA (TNF Pharma)|YCBD - Net Assets per Share|PRFX: Book Value per Share|Book Value per Share Altamira Therapeutics Ltd.|LIPO - Accounting Value per Share|Accounting Value of a Share optinose.com|Book Value per Share PIRS (Pieris Pharmaceuticals, Inc.)|Accounting Value per Share PROC (Procaps Group)|PTPI: Net Assets per Single Share|Qilian International Corp - Net Asset Value per Share|Net Assets per Single Share Acelyrin, Inc. (SLRN)|TFFP: Accounting Value of a Share